Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Brainsway (BWAY) Receivables - Other (2018 - 2020)

Brainsway posted quarterly Receivables - Other of $1.5 million for Q4 2020, up 7.5% year-on-year from $1.4 million in Q1 2020, and up 7.5% on a QoQ basis from $1.4 million in Q4 2019.

Brainsway (BWAY) has 3 years of Receivables - Other data on file, last reported at $1.5 million in Q4 2020.

  • For the quarter ending Q4 2020, Receivables - Other rose 7.5% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2020 stood at $1.5 million (up 7.5% YoY), and the FY2020 full-year result was $1.5 million, up 7.5% from the prior year.
  • Receivables - Other for Q4 2020 stood at $1.5 million, up from $1.4 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.5 million in Q4 2020 and bottomed at $1.4 million in Q4 2019.
  • The 3-year median for Receivables - Other is $1.5 million (2018), against an average of $1.5 million.
  • The widest annual swing landed in 2019, when Receivables - Other slipped 5.18%; it then grew 7.5% in 2020.
  • A 3-year view of Receivables - Other shows it stood at $1.5 million in 2018, then slipped by 5.18% to $1.4 million in 2019, then climbed by 7.5% to $1.5 million in 2020.
  • The last three Receivables - Other figures came in at $1.5 million (Q4 2020), $1.4 million (Q4 2019), and $1.5 million (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 1.53 Mn
Dec 31, 2020 1.53 Mn
Dec 31, 2019 1.43 Mn
Dec 31, 2019 1.43 Mn
Dec 31, 2018 1.51 Mn
Dec 31, 2018 1.51 Mn